XML 112 R100.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies (Details) - CM Life Sciences, Inc. - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 10, 2021
Sep. 04, 2020
Mar. 31, 2021
Dec. 31, 2020
Commitments and Contingencies (Details) [Line Items]        
Common stock par value (in dollars per share)     $ 0.0001  
Aggregate amount not to exceed     $ 343,000,000  
Denominator for consideration payable formula (in dollars per share)     $ 10  
Issuable shares of common shares outstanding at second anniversary     11.00%  
Earn Out share price at second anniversary (in dollars per share)     $ 0.00  
Sponsor        
Commitments and Contingencies (Details) [Line Items]        
Number of shares issued (in shares) 35,000,000      
Aggregate purchase price $ 350,000,000      
Class A common stock        
Commitments and Contingencies (Details) [Line Items]        
Common stock par value (in dollars per share)     0.00001  
Class B common stock        
Commitments and Contingencies (Details) [Line Items]        
Common stock par value (in dollars per share)     $ 0.00001  
Over-allotment option        
Commitments and Contingencies (Details) [Line Items]        
Number of shares issued (in shares)   5,775,000    
Sale of stock shares price (in dollars per share)   $ 10.00    
Gross proceeds   $ 442,750,000    
Forward Purchase Agreement | Class A common stock | Casdin and Corvex        
Commitments and Contingencies (Details) [Line Items]        
Number of shares issued (in shares)     15,000,000 15,000,000
Sale of stock shares price (in dollars per share)     $ 10.00 $ 10.00
Gross proceeds     $ 150,000,000 $ 150,000,000
Underwriting Agreement | Over-allotment option        
Commitments and Contingencies (Details) [Line Items]        
Deferred fee price per share     $ 0.35 $ 0.35
Aggregate underwriting commissions     $ 15,496,250 $ 15,496,250